Mirum Pharmaceuticals

Mirum Pharmaceuticals (operating at mirumpharma.com) is a biopharmaceutical company engineered for developing and delivering treatments for rare diseases. Founded in Not specified by Chris Peetz and Eric Bjerkholt and headquartered in Not specified, Mirum Pharmaceuticals focuses on conditions where the urgency and sustained commitment are required. Under the hood, the company conducts clinical trials to investigate potential treatments for rare diseases. This allows patients and families affected by rare diseases to access high-impact medicines. Backed by up to $210 million funding arrangement with Oberland Capital.